Jianmin Pharmaceutical Group Co., Ltd. (600976.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 26.28

From 52W high−36.39%

Volume617900.00

Market capCNY 4.23B

P/E (TTM)11.8x

P/S (TTM)1.2x

Div yield3.40%

Key dataSep 18, 2026

Open

CNY 26.28

From 52W high

−36.39%

Volume

617900.00

Market cap

CNY 4.23B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.8x

P/E (TTM)

11.8x

RSI (14)

36.8

MomentumView details →

1D Return

+0.15%

YTD Return

−21.24%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

11.8x

EV/EBITDA

8.8x

EV/Sales

1.2x

P/S (TTM)

1.2x

P/B (TTM)

1.6x

ProfitabilityView details →

Gross Margin

60.37%

Net Margin

10.07%

EBITDA Margin

13.60%

ROE (TTM)

12.30%

ROA (TTM)

7.20%

Asset Turnover

0.73x

GrowthView details →

Revenue YoY

−2.22%

EPS YoY

−8.90%

FCF YoY

+73.02%

Revenue CAGR 3Y

−2.54%

EPS CAGR 3Y

−4.01%

EBITDA YoY

—

MomentumView details →

1D Return

+0.15%

YTD Return

−21.24%

1Y Return

−36.10%

RSI (14)

36.8

vs 50D SMA

−6.33%

vs 200D SMA

−15.79%

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

1.55x

Quick Ratio

1.36x

Div Yield

3.40%

Div Rate

CNY 0.90

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

CNY 0.58

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

3.35B

Net Income (TTM)

337.40M

Op. CF (TTM)

345.27M

Latest newsMore news →

Jianmin Group announced that its Crisaborole Ointment received approval from China's National Medical Products Administration and was launched on the market.17d ago

Jianmin Group announced its 2026 half-year results: revenue of 1.611 billion yuan, down 10.72% year-on-year; net profit attributable to shareholders of 177 million yuan, down 19.68% year-on-year.32d ago

Similar companies

太龙药业600222.SH 方盛制药603998.SH Xuanzhubio-b02575.HK ST中珠600568.SH Indivior Pharmaceuticals IncINDV 联环药业600513.SH Find similar companies →

Latest newsMore news →

Jianmin Group announced that its Crisaborole Ointment received approval from China's National Medical Products Administration and was launched on the market.17d ago Jianmin Group announced its 2026 half-year results: revenue of 1.611 billion yuan, down 10.72% year-on-year; net profit attributable to shareholders of 177 million yuan, down 19.68% year-on-year.32d ago